Furthermore, the rapid osmotic diuresis with neutral effects on electrolyte balance qualifies SGLT2 inhibitors as a valid, safe and intriguing alternative to thiazide diuretics in type 2 diabetic patients. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.